NNovo Nordisk Read More Novo Nordisk Pins Hopes on CagriSema Data and Wegovy Combo Study to Reverse Stock’s Slide2026-06-05 Novo Nordisk unveils first Phase 3 CagriSema diabetes results at ADA, launches Wegovy combo trial with Veru, as…